Genenta Science SPA (GNTA)
3.30
+0.12
(+3.77%)
USD |
NASDAQ |
May 17, 16:00
3.30
0.00 (0.00%)
After-Hours: 17:02
Genenta Science Price to Book Value: 2.662 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.565 |
| May 15, 2024 | 2.581 |
| May 14, 2024 | 2.597 |
| May 13, 2024 | 2.828 |
| May 10, 2024 | 2.500 |
| May 09, 2024 | 2.605 |
| May 08, 2024 | 2.984 |
| May 07, 2024 | 2.960 |
| May 06, 2024 | 2.815 |
| May 03, 2024 | 2.801 |
| May 02, 2024 | 2.670 |
| May 01, 2024 | 2.650 |
| April 30, 2024 | 2.484 |
| April 29, 2024 | 2.379 |
| April 26, 2024 | 2.089 |
| April 25, 2024 | 2.350 |
| April 24, 2024 | 2.057 |
| April 23, 2024 | 2.928 |
| April 22, 2024 | 3.183 |
| April 19, 2024 | 3.146 |
| April 18, 2024 | 3.158 |
| April 17, 2024 | 2.420 |
| April 16, 2024 | 2.768 |
| April 15, 2024 | 2.776 |
| April 12, 2024 | 2.796 |
| Date | Value |
|---|---|
| April 11, 2024 | 2.799 |
| April 10, 2024 | 2.753 |
| April 09, 2024 | 2.678 |
| April 08, 2024 | 2.662 |
| April 05, 2024 | 2.648 |
| April 04, 2024 | 2.670 |
| April 03, 2024 | 2.667 |
| April 02, 2024 | 2.694 |
| April 01, 2024 | 2.912 |
| March 28, 2024 | 2.823 |
| March 27, 2024 | 2.952 |
| March 26, 2024 | 3.062 |
| March 25, 2024 | 3.172 |
| March 22, 2024 | 3.226 |
| March 21, 2024 | 3.226 |
| March 20, 2024 | 3.307 |
| March 19, 2024 | 3.307 |
| March 18, 2024 | 3.315 |
| March 15, 2024 | 3.146 |
| March 14, 2024 | 3.226 |
| March 13, 2024 | 3.352 |
| March 12, 2024 | 3.509 |
| March 11, 2024 | 3.204 |
| March 08, 2024 | 3.204 |
| March 07, 2024 | 3.263 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.853
Minimum
Nov 14 2022
15.58
Maximum
Dec 27 2021
3.371
Average
3.254
Median
May 09 2023
Price to Book Value Benchmarks
| Stevanato Group SPA | 3.932 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.2114 |
Price to Book Value Related Metrics
| Price | 3.30 |
| Earnings Yield | -21.04% |
| Market Cap | 60.12M |